| CRPF group (n = 18) Median (IQR) | Non-CRPF group (n = 168) Median (IQR) | P value |
---|---|---|---|
WBC (× 109/L) | |||
 POD1 | 13.82 (10.72–15.52) | 12.50 (9.94–16.28) | 0.242 |
 POD2 | 19.97 (15.93–23.36) | 16.30 (12.47–18.80) | 0.003 |
 POD3 | 15.54 (12.76–20.01) | 12.52 (9.91–15.78) | 0.001 |
 POD5 | 13.08 (10.02–20.82) | 9.85 (7.72–11.97) | 0.009 |
 POD7 | 15.35 (10.91–20.79) | 9.66 (7.86–13.24) |  < 0.001 |
PCT (ng/mL) | |||
 POD1 | 1.33 (0.70–2.34) | 0.31 (0.18–0.64) |  < 0.001 |
 POD2 | 5.76 (3.92–8.21) | 0.63 (0.40–1.26) |  < 0.001 |
 POD3 | 3.88 (2.67–6.02) | 0.51 (0.29–1.00) |  < 0.001 |
 POD5 | 1.51 (0.94–2.15) | 0.32 (0.19–0.51) |  < 0.001 |
 POD7 | 0.73 (0.46–0.99) | 0.21 (0.14–0.35) |  < 0.001 |
CRP (mg/L) | |||
 POD1 | 81.00 (46.80–121.53) | 40.44 (21.87–71.72) | 0.045 |
 POD2 | 247.89 (219.44–257.00) | 174.57 (130.02–237.79) |  < 0.001 |
 POD3 | 201.72 (141.88–261.45) | 179.50 (138.12–246.40) | 0.081 |
 POD5 | 107.16 (70.97–186.72) | 89.52 (52.45–129.37) | 0.007 |
 POD7 | 80.70 (73.40–193.69) | 51.85 (29.25–116.08) | 0.001 |
DFA (IU/L) | |||
 POD3 | 789.75 (67.75–3906.50) | 32.00 (30.00–2802.90) | 0.004 |